Symbioze won the Pharmapack Award 2021
Symbioze, the smart, high volume and sustainable on-body injector platform developed by Nemera, wins the ‘Connected Devices and Wearables’ Award at Pharmapack 2021
On October 12th, during the Pharmapack Awards Ceremony, a team of industry experts awarded Symbioze, Nemera’s large-volume on-body injector, with the Pharmapack Award in the “Connected Devices and Wearables” category.
Nemera’s novel on-body injector platform, Symbioze, comprises of a reusable main unit and disposable prefilled drug container module. It offers an ideal balance between the need to deliver advanced formulations at high volumes, up to 20 ml – and patient’s ease-of-use required for self-administration at home.
It is the perfect combination between design robustness, ease of use, connectivity, and sustainability, for a seamless and enhanced injection experience.
Symbioze is specifically tailored to administer complex drugs, such as biologic therapies, thanks to a highly engineered, reliable drug delivery system. It is suitable for large volumes such as 20ml and beyond, while preserving the formulation integrity – which is critical especially with monoclonal antibodies. It is designed to reconcile complex drugs injection with stakeholders’ (patients, HCP or payers) most demanding needs, with enough flexibility for adjustment to any pathology, targeted patient population and drug posology. Its reusable core technology can be re-used across multiple injections, leveraging its sustainable benefit for pharmaceutical players.
“We are very delighted and pleased to receive this prestigious award. This is a recognition to our long-standing commitment to put patients first as well as our innovation capabilities.” – said Séverine Duband, Nemera’s Marketing Director, Drug Delivery Devices – “Over the last decade, several trends impacted the parenteral environement: shift towards at-home and value-based care, growth of biologics, connected health technologies, waste management. These continuously fueled a need for an easy self administration of large dose volumes. This is why, we developped our on-body injector platform Symbioze, to deliver large volumes at home, in a sustainable and user-friendly way.”
Bernhard Rohn, VP of Strategy and Marketing, added: “We are very delighted to have received the Pharmapack award for our Symbioze wearable. We developed Symbioze to provide an intuitive and easy-to-use solution for patients, combining high injection volumes up to 20ml, a sustainable reusable/disposable product architecture and compatibility with standard pharmaceutical filling- and final-assembly processes.”